0.0540
-0.0012
(-2.17%)
At close: January 14 at 2:58:57 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
37.5000
0.0590
0.6430
Cost of Revenue
--
--
18.6440
0.0250
0.1950
Gross Profit
--
--
18.8560
0.0340
0.4480
Operating Expense
1,668.8310
--
2,820.8950
29,800.6690
14,849.0990
Operating Income
-1,668.8310
--
-2,802.0390
-29,800.6350
-14,848.6510
Net Non Operating Interest Income Expense
-105.7930
--
-78.8450
-618.2510
-546.2280
Other Income Expense
115.0850
--
1,193.3830
-130.2970
-316.5210
Pretax Income
-1,659.5390
--
-1,687.5010
-30,549.1830
-15,711.4000
Net Income Common Stockholders
-1,659.5390
--
-1,687.5010
-30,549.1830
-15,711.4000
Diluted NI Available to Com Stockholders
-1,659.5390
--
-1,687.5010
-30,549.1830
-15,711.4000
Basic EPS
-0.00
-0.01
-0.01
-0.14
-0.09
Diluted EPS
-0.00
-0.01
-0.01
-0.14
-0.09
Basic Average Shares
246,319.1580
239,080.2820
229,718.1420
225,741.6840
183,756.2710
Diluted Average Shares
249,633.2220
239,080.2820
229,718.1420
225,741.6840
183,756.2710
Total Operating Income as Reported
-1,668.8310
--
-2,802.0390
-29,800.6350
-14,848.6510
Total Expenses
1,668.8310
--
2,839.5390
29,800.6940
14,849.2940
Net Income from Continuing & Discontinued Operation
-1,659.5390
--
-1,687.5010
-30,549.1830
-15,711.4000
Normalized Income
-1,774.6240
--
-1,477.9030
-30,114.6130
-15,394.8790
Interest Expense
105.7930
--
78.8450
618.2510
546.2280
Net Interest Income
-105.7930
--
-78.8450
-618.2510
-546.2280
EBIT
-1,553.7460
--
-1,608.6560
-29,930.9320
-15,165.1720
EBITDA
-1,548.6530
--
-1,604.6060
-29,930.9320
-15,165.1720
Reconciled Cost of Revenue
--
--
18.6440
0.0250
0.1950
Reconciled Depreciation
5.0930
--
4.0500
--
--
Net Income from Continuing Operation Net Minority Interest
-1,659.5390
--
-1,687.5010
-30,549.1830
-15,711.4000
Total Unusual Items Excluding Goodwill
115.0850
--
-209.5980
-434.5700
-316.5210
Total Unusual Items
115.0850
--
-209.5980
-434.5700
-316.5210
Normalized EBITDA
-1,663.7380
--
-1,395.0080
-29,496.3620
-14,848.6510
12/31/2020 - 2/14/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TCHBF Tecan Group AG
208.03
0.00%
STMN.SW Straumann Holding AG
118.50
+1.59%
WST West Pharmaceutical Services, Inc.
328.96
-3.13%
COLOBc.XC
TCGGY Tecan Group AG
83.50
0.00%
SKANz.XC
ANSLY Ansell Limited
85.32
0.00%
SRT3.BE Sartorius AG
244.20
+4.36%
BGMD BG Medicine, Inc.
0.0001
0.00%
STRG.TA Storage Drop Storage Technologies Ltd
39.00
+20.00%